The Swiss stock market closed slightly lower on Monday, taking a slight pause following the significant gains of the past 2 weeks. The European Central bank was in focus at the beginning of the new trading week, as was the upcoming meetings for the Greek Prime Minister.
In the afternoon, the European Central Bank rejected a report about a possible capping of risk premiums on government bonds. Germany's Spiegel magazine reported Sunday, without mentioning its sources, that the ECB was considering setting limits on yields of Eurozone sovereign bonds.
The Swiss Market Index declined by 0.35 percent Monday and finished at 6,506.25. The Swiss Leader Index fell by 0.38 percent and the Swiss Performance Index lost 0.31 percent.
Bank stocks were under pressure on Monday. Shares of UBS declined by 1.8 percent and Credit Suisse dropped by 1.3 percent. Julius Baer also decreased by 1.0 percent.
Shares of Nobel Biocare rose by 1.9 percent, ahead of its first half of the year report, which is due out on Wednesday. Sonova climbed by 1.4 percent, Sika gained 1.3 percent and ABB rose by 0.6 percent. Richemont and Swatch both increased by 0.7 percent.
For comments and feedback contact: editorial@rttnews.com
Market Analysis
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.